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Abstract  
Cerebral venous thrombosis (CVT) has been reported as an uncommon and devastating complication of ulcerative colitis (UC), with an annual 
incidence varying between 0,5 to 6,7%. It is suspected to be a consequence of the hypercoagulable state occurring during disease relapse. We 
report a case of 22-year-old female patient presenting with CVT revealing an UC. Our case raises the awareness among health professionals about 
the inflammatory bowel diseases (IBD) as a rare etiology of CVT, and signifies the importance of considering antithrombotic prophylaxis in all 
hospitalised IBD patients, especially those with active disease. 
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Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that 
may have various neurologic manifestations which seem to be more 
common than previously estimated. There is evidence of an 
increased incidence of thrombotic complications in patients with 
ulcerative colitis (UC) and Crohn’s disease. However, cerebral 
vascular involvement is rare and only 1.6% of total cerebral venous 
thrombotic events are associated with IBD [1,2]. We report a case 
of 22-year-old female patient presenting with CVT revealing an UC. 
  
  
Patient and observation 
 
A 22 year-old female was presented to our department with a 
sudden onset of language disorders. A week earlier, she 
experienced an intense and diffuse abdominal pain, bloody diarrhea 
and intermittent vomiting. She had no particular medical history, 
especially no cardiovascular risk factors. Physical examination 
revealed a pale , febrile patient at 39 °C, with low blood pressure 
(90/60 mmHg) and tachycardia at 105 beats per minute. The 
abdomen was sensitive and on the digital rectal examination the 
stall was stained with blood. Neurological examination found a 
Wernicke aphasia without other deficiencies. A contrast-enhanced 
computed tomography scan of the brain showed a left temporo-
parietal venous infarct with incomplete enhancement of left 
transverse sinus. A cerebral angio-magnetic resonance imaging 
confirmed the venous infarct and revealed an absence of signal in 
the left transverse and sigmoid sinus (Figure 1, Figure 2, Figure 3). 
Laboratory findings showed anemia at 7g/dl , the white blood cell 
count was elevated at 13000/mm3. Erythrocyte sedimentation rate 
was 90 mm in the first hour. CRP elevated at 103mg/l. 
Prothrombine time and PTT were normal. Liver function, renal 
function, serum electrolytes were within normal limits. His 
prothrombotic workup such as factor V Leiden, protein C and S, 
factor VIII, and antithrombin III was normal. Antinuclear antibodies 
and anticardiolipin antibodies were negative and homocysteine 
levels were normal. In addition, lumbar puncture and stool 
examination were also normal whereas the sigmoidoscopy 
completed by a total colonoscopy with biopsies have found a 
pancolic ulcerative colitis. Taking into account clinical and laboratory 
criterias of Truelove-Witts (8-10 hemorrhagic motions per day, Hb 
7g / dl CRP 103 mg/l) the diagnosis of UC severe flare was retained 
and the patient was given intravenous pulse steroid therapy 
(methylprednisolone 40mg / d) in addition to anticoagulation 
therapy. She was put on maintenance treatment with 
Acénocoumarol and prednisolone started with 60 mg/day and slowly 
tapered off over 5 months. We observed a regression of 
neurological and bowel symptoms after the first week and a 






Inflammatory bowel diseases comprise two major entities: 
ulcerative colitis and Crohn disease. UC is an idiopathic chronic IBD 
that is a consequence of complex interaction of environmental 
factors and genetic susceptibility [3]. It often occurs in patients 
between the ages of 20 and 30 years, with a second peak between 
the ages of 70 and 80 years. UC can be regarded as a systemic 
disease with numerous extraintestinal complications. Neurologic 
manifestations are protean, rare and particularly severe [4]. There 
is a high thromboembolic risk in IBD patients with an annual 
incidence varying between 0,5 [5] to 6,7% [6]. Deep venous 
thrombosis and pulmonary thromboembolism are the two most 
common thrombotic complications of UC [7]. CVT has been reported 
as an uncommon but severe complication of UC and CD, ranging in 
frequency from 1.3% up to 7.5% of cases yearly depending on the 
clinical study [8]. Various mechanisms have been postulated for 
thrombosis in UC which include hypercoagulation (elevated FVIII, 
fibrinogen, decrease in antithrombin, protein S and protein C), 
hypofibrinolysis [elevated PAI-1 and lipoprotein (a)], platelet 
abnormalities, endothelial dysfunction (increased von Willebrand 
factor), and immunological abnormalities (antiphosphlipid 
antibodies) [9]. Concomitant causes of CVT were systematically 
searched for in our patient. There were no risk factors and the 
prothrombotic workup was negative. Probably in the acute phase of 
the illness our patient may have had a hypercoagulable state. The 
clinical presentation of CVT, consisting of headaches, focal signs, 
seizures, or encephalopathy, and the sites of the venous occlusions 
are similar to the usual cerebral venous thrombosis. They can occur 
from 2 months to 17 years after the first attack of IBD. Occasionally, 
the diagnosis of IBD is established only when CVT occurs [10,11]. 
Although IBD may be asymptomatic when the venous thrombosis 
occurs, almost all patients had biologic markers of inflammation 
such as elevated leukocyte count, CRP, or ESR. The first-line 
treatment for CVT is adjusted-dose unfractionated heparin or low-
molecular-weight heparin, but its risks should be carefully weighed 
in light of possible hemorrhagic complications [12]. Endovascular 
thrombolysis was tried in a few cases, with favorable and safe 
outcomes [13]. This limited evidence supports the use of approved 
guidelines for cerebral venous thrombosis management [12, 14] 
also when associated with IBD. The prognosis is usually good, but a 





Among the multiple causes of CVT, the IBD must always be in mind. 
Early diagnosis and management might improve its poor prognosis. 
Subsequently, prophylactic anti-coagulation must be considered in 
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Figure 1: Magnetic resonance imaging. Contrast enhanced Axial T1 
image showing a temporoparietal hypointense area with few 
petechial lesions  
Figure 2: Magnetic resonance imaging. Gadolinium-enhanced axial 
T1 image showing a meningeal enhancement at the left parietal 
lobe  
Page number not for citation purposes 3
Figure 3: Magnetic resonance venogram image showing abrupt 
loss of flow related signal at the proximal left transverse sinus 
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Figure 1: Magnetic resonance imaging. 
Contrast enhanced Axial T1 image showing a 
temporoparietal hypointense area with few 
petechial lesions  
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Figure 2: Magnetic resonance imaging. Gadolinium-
enhanced axial T1 image showing a meningeal 





Figure 3: Magnetic resonance venogram image showing 
abrupt loss of flow related signal at the proximal left 
transverse sinus continuing distally to involve the left 
sigmoid 
 
